|8-KFeb 18, 7:13 AM ET

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 8-K

Research Summary

AI-generated summary

Updated

Charles River Laboratories Reports Q4 and FY 2025 Results

What Happened

  • Charles River Laboratories International, Inc. (CRL) filed an 8-K on February 18, 2026 (Item 2.02) announcing its financial results for the fourth quarter and fiscal year ended December 27, 2025. The company issued a press release with those results and attached it as an exhibit to the filing.
  • The press release includes standard "safe harbor" language under the Private Securities Litigation Reform Act, noting that some statements are forward-looking and subject to risks described in CRL’s SEC filings.

Key Details

  • Filing date: February 18, 2026 (8-K reporting results under Item 2.02).
  • Period covered: Fourth quarter and fiscal year ended December 27, 2025.
  • Press release attached as Exhibit 99.1; interactive XBRL cover page included as Exhibit 104.
  • The 8-K states the press release’s forward-looking statements are subject to risks set forth in CRL’s SEC filings.

Why It Matters

  • This 8-K signals CRL has released its latest earnings and revenue performance for investors to review; the press release (exhibit) is the primary source for the actual financial figures, guidance, and management commentary.
  • The safe-harbor note means management may have provided forward-looking guidance or expectations—investors should read the press release and CRL’s risk disclosures in prior SEC filings to understand assumptions and risks before drawing conclusions.